Serum to tackle age-old problem is here. Prepare for mayhem
· Boots expects scramble for 'miracle' cure for wrinkles · Cream finally back in stock after supplies ran out
GlaxoSmithKline gets approval for nasal spray
The company said the Veramyst spray, a potential blockbuster for treating hay fever, would be available on prescription in the US by the end of May, and should start selling in Europe by the end of the year. By Marianne Barriaux.
US generics put pressure on GlaxoSmithKline
3.45pm update: Drugs giant posted a fall in sales and profits for the first quarter of the year this morning, due to a strong pound and tough generic competition in the US, while Shire raises its earnings guidance for this year. By Marianne Barriaux.
Prudential to sell health cover on high street as market share falls
Prudential is to sell personal medical insurance in 1,500 Boots stores in an attempt to grab a higher share of the £3bn-a-year market.
Prudential to sell personal medical insurance in Boots stores
5.45pm update: Partnership announced as the insurer revealed another drop in sales of life and pensions products in the UK. By Jill Treanor and Graeme Wearden.
L’Oréal au naturel – because it’s worth a lot
The £650m acquisition of Body Shop by the world's biggest cosmetic group marked a new trend in the industry.
Fruit, veg and a trip to the GP as stores are asked to open surgeries
· Areas with fewer doctors to be targeted by scheme· Boots and Tesco among retailers thought suitable
NHS ‘spending £500m a year too much on drugs’
2.30pm update: The Office of Fair Trading says the health service is handing pharmaceutical companies too much money for some branded prescription medicines.
Biotech firm in cannabis breakthrough
9.45am: GW Pharmaceuticals today signed up Japan's Otsuka
to develop and market its pioneering cannabis-based drug Sativex in the US. By Julia Kollewe.